Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew J Gale

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Journal of Immunology (Baltimore, Md. : 1950)|September 26, 2018
Augmentation of Human Monocyte Responses to Lipopolysaccharide by the Protein S and Mer/Tyro3 Receptor Tyrosine Kinase AxisNicole D Barth, John A Marwick, Mary Jo Heeb, et al.
The Journal of Clinical Investigation|June 1, 2013
Antigenic liposomes displaying CD22 ligands induce antigen-specific B cell apoptosisMatthew S Macauley, Fabian Pfrengle, Christoph Rademacher, et al.
Plos One|August 16, 2014
An engineered factor Va prevents bleeding induced by anticoagulant wt activated protein CAnnette von Drygalski, Vikas Bhat, Andrew J Gale, et al.
Blood Advances|August 11, 2020
An engineered factor Va prevents bleeding induced by direct-acting oral anticoagulants by different mechanismsAnnette von Drygalski, Vikas Bhat, Andrew J Gale, et al.
Theranostics|September 14, 2017
Sensitive <i>in vivo</i> Visualization of Breast Cancer Using Ratiometric Protease-activatable Fluorescent Imaging Agent, AVB-620Marcel Miampamba, Junjie Liu, Alec Harootunian, et al.
Thrombosis Research|April 19, 2011
Engineered virus-like nanoparticles reverse heparin anticoagulation more consistently than protamine in plasma from heparin-treated patientsAndrew J Gale, Darlene J Elias, Patricia M Averell, et al.
Biomacromolecules|September 27, 2017
Heparin Binding to an Engineered Virus-like Nanoparticle AntagonistHo Yong Cheong, Myles Groner, Kevin Hong, et al.
Blood|July 22, 2017
Selective factor VIII activation by the tissue factor-factor VIIa-factor Xa complexYuichi Kamikubo, G Loredana Mendolicchio, Antonella Zampolli, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Journal of Immunology (Baltimore, Md. : 1950)|September 26, 2018
Augmentation of Human Monocyte Responses to Lipopolysaccharide by the Protein S and Mer/Tyro3 Receptor Tyrosine Kinase AxisNicole D Barth, John A Marwick, Mary Jo Heeb, et al.
The Journal of Clinical Investigation|June 1, 2013
Antigenic liposomes displaying CD22 ligands induce antigen-specific B cell apoptosisMatthew S Macauley, Fabian Pfrengle, Christoph Rademacher, et al.
Plos One|August 16, 2014
An engineered factor Va prevents bleeding induced by anticoagulant wt activated protein CAnnette von Drygalski, Vikas Bhat, Andrew J Gale, et al.
Blood Advances|August 11, 2020
An engineered factor Va prevents bleeding induced by direct-acting oral anticoagulants by different mechanismsAnnette von Drygalski, Vikas Bhat, Andrew J Gale, et al.
Theranostics|September 14, 2017
Sensitive <i>in vivo</i> Visualization of Breast Cancer Using Ratiometric Protease-activatable Fluorescent Imaging Agent, AVB-620Marcel Miampamba, Junjie Liu, Alec Harootunian, et al.
Thrombosis Research|April 19, 2011
Engineered virus-like nanoparticles reverse heparin anticoagulation more consistently than protamine in plasma from heparin-treated patientsAndrew J Gale, Darlene J Elias, Patricia M Averell, et al.
Biomacromolecules|September 27, 2017
Heparin Binding to an Engineered Virus-like Nanoparticle AntagonistHo Yong Cheong, Myles Groner, Kevin Hong, et al.
Blood|July 22, 2017
Selective factor VIII activation by the tissue factor-factor VIIa-factor Xa complexYuichi Kamikubo, G Loredana Mendolicchio, Antonella Zampolli, et al.
Pageof 3